The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
May 16th 2024
Other findings from the latest Kaiser Family Foundation Health Tracking Poll shed light on public awareness, use, and opinions on Medicare coverage of glucagon-like peptide-1 (GLP-1) drugs.
Cost-effectiveness of Intensification With SGLT2 Inhibitors for Type 2 Diabetes
Adding a sodium-glucose co-transporter 2 (SGLT2) inhibitor dominated switching to a glucagon-like peptide 1 receptor agonist over the lifetimes of patients with type 2 diabetes not at glycated hemoglobin A1c target after treatment with metformin plus a dipeptidyl peptidase-4 inhibitor.
Read More
Dr Deepak Bhatt on the Potential Stroke Benefits of SGLT1s
July 27th 2021Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, discusses whether sodium glucose co-transporter 1 (SGLT1) inhibitors can yield stroke benefits in patients with type 2 diabetes.
Watch
Dr Michelle Litchman Outlines the Benefits of Online Diabetes Peer Support Groups
July 14th 2021Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, describes the results of a study that looked at diabetes technology use and online peer support systems among Spanish-speaking patients. Findings showed that when these 2 interventions are used in conjunction, a positive feedback loop forms.
Watch
Dr Deepak Bhatt Discusses SCORED, SOLOIST Trial Results
June 29th 2021Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, outlines the benefits of sotagliflozin for individuals with type 2 diabetes and chronic kidney disease or heart failure.
Watch
NIH-Funded Study Finds Liraglutide, Insulin Better Than Other Options for Maintaining A1C
June 29th 2021The study was launched the same month as the first US approval of a sodium-glucose co-transporter 2 inhibitor, and the failure to include a drug from this class was viewed by a commentator as a weakness of GRADE.
Read More
Dr Michelle Litchman on Technology Interventions for Spanish-Speaking Patients With T2D
June 27th 2021Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, highlights her research on the benefits of concurrent continuous glucose monitoring and online peer support groups for Spanish-speaking patients with diabetes.
Watch
Dr David McIntyre Outlines How the COVID-19 Pandemic Impacted GD Management, Diagnoses
June 25th 2021David McIntyre, MD, FRACP, gives an overview of his talk "Diagnosis and Management of Diabetes in Pregnancy During the COVID-19 Pandemic," to be presented at the American Diabetes Association's (ADA) 81st Scientific Sessions.
Watch